As RUNX1 has been shown to be involved in female sex development and is a mediator of female hormone signalling, with RUNX1 dysregulation involved in breast, ovarian, and uterine cancers,44,45 it is important to consider that RUNX1 may have differing roles within the female vs. male cardiovascular system. Here, RUNX1 is linked to uterine cancer.